D.E. Shaw & Co
DPLO

D.E. Shaw & Co’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

D.E. Shaw & Co’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,134,345
Closed -$4.54M – 4455
2019
Q4 		$4.54M Sell
1,134,345
-29,662
-3% -$139K 0.01% 1808
2019
Q3 		$5.7M Buy
1,164,007
+173,834
+18% +$973K 0.01% 1550
2019
Q2 		$6.03M Buy
990,173
+224,067
+29% +$1.19M 0.01% 1466
2019
Q1 		$4.45M Buy
766,106
+719,819
+1,555% +$7.43M 0.01% 1619
2018
Q4 		$623K Sell
46,287
-227,817
-83% -$3.84M ﹤0.01% 2965
2018
Q3 		$5.32M Buy
274,104
+229,881
+520% +$4.89M 0.01% 1550
2018
Q2 		$1.13M Sell
44,223
-215,160
-83% -$5.02M ﹤0.01% 2632
2018
Q1 		$5.23M Sell
259,383
-301,658
-54% -$7.04M 0.01% 1377
2017
Q4 		$11.3M Buy
561,041
+233,456
+71% +$4.59M 0.02% 960
2017
Q3 		$6.79M Sell
327,585
-63,004
-16% -$1.07M 0.01% 1172
2017
Q2 		$5.78M Buy
390,589
+367,691
+1,606% +$6.13M 0.01% 1235
2017
Q1 		$365K Buy
+22,898
New +$330K ﹤0.01% 2887
2015
Q2 		– Sell
-36,599
Closed -$1.27M – 3948
2015
Q1 		$1.27M Buy
36,599
+12,540
+52% +$341K ﹤0.01% 2374
2014
Q4 		$658K Buy
+24,059
New +$584K ﹤0.01% 3129

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

D.E. Shaw & Co's DPLO Position: Q1 2020 in Review

D.E. Shaw & Co sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 1,134,345 shares — an estimated $4.54M sold.

D.E. Shaw & Co first reported a position in DPLO in Q4 2014 and held it in 14 quarters. The position peaked at $11.3M in Q4 2017. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • D.E. Shaw & Co reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,134,345 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $4.54M.
  • D.E. Shaw & Co first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 14 quarters.
  • D.E. Shaw & Co's DIPLOMAT PHARMACY, INC. position peaked at $11.3M in Q4 2017.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.